Novel 1,3,4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel 1,3,4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume -, Issue -, Pages -
Publisher
Future Science Ltd
Online
2019-03-21
DOI
10.4155/fmc-2018-0378
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification and development of benzoxazole derivatives as novel bacterial glutamate racemase inhibitors
- (2018) Prasanthi Malapati et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A Facile Synthesis and Antituberculosis Properties of Almazole D and Its Enantiomer
- (2017) Dhanaji M. Lade et al. ChemistrySelect
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
- (2017) Antoine Daina et al. Scientific Reports
- Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents
- (2016) N.C. Desai et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India
- (2016) Amita Jain et al. INDIAN JOURNAL OF MEDICAL RESEARCH
- Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis
- (2016) Galina Karabanovich et al. JOURNAL OF MEDICINAL CHEMISTRY
- Isoniazid metabolism and hepatotoxicity
- (2016) Pengcheng Wang et al. Acta Pharmaceutica Sinica B
- Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis
- (2016) Chao Gao et al. Scientific Reports
- Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis
- (2015) Alexander S. Pym et al. EUROPEAN RESPIRATORY JOURNAL
- Lead Optimization of a Novel Series of Imidazo[1,2-a]pyridine Amides Leading to a Clinical Candidate (Q203) as a Multi- and Extensively-Drug-Resistant Anti-tuberculosis Agent
- (2014) Sunhee Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- P450-Mediated O-Demethylated Metabolite Is Responsible for Rat Hepatobiliary Toxicity of Pyridyltriazine-Containing PI3K Inhibitors
- (2014) Raju Subramanian et al. TOXICOLOGICAL SCIENCES
- Sensititre MYCOTB MIC Plate for Testing Mycobacterium tuberculosis Susceptibility to First- and Second-Line Drugs
- (2013) Jongseok Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
- (2013) Kevin Pethe et al. NATURE MEDICINE
- Molecular properties prediction and synthesis of novel 1,3,4-oxadiazole analogues as potent antimicrobial and antitubercular agents
- (2011) Mohamed Jawed Ahsan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
- (2009) V. Makarov et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now